Open access
Aug 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells
A versatile and modular platform that enables programmable control of CAR T-cell activity is reported, offering a new strategy to overcome tumor heterogeneity and immune suppression.
Cheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo et al.
· Cancer immunology research · 0 citations